OReO-ENGOT-Ov38 (ENGOT/GCIG/AZ)

Trial Description: 
Phase III study Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Recurrent Ovarian
Trial Status: 
Recruiting
Contact person: